Moody's Affirmed Ascension Credit Rating

The health system’s steady rating reflects its national scale and the recent Amsurg acquisition despite ongoing margin pressures.

Updated on Oct. 2, 2026 in Healthcare

Isometric editorial illustration of clean, multi-level clinical buildings representing a national healthcare system. — Moody's Ratings affirmed an Aa3 credit rating for Ascension, highlighting the hospital operator's market scale and growth from the Amsurg acquisition. AI Illustration. Upload story photo >

Live Poll

Is the quality of affordable healthcare in your area getting better or worse?

Moody's Ratings has affirmed an Aa3 credit rating for the hospital operator Ascension, citing its leading market positions and growth initiatives. The system, which operates 91 hospitals and 312 ambulatory surgery centers across 36 states, maintains a stable outlook.

Why it matters

The affirmation underscores the strategic importance of scaling non-acute service lines to offset broader financial headwinds. While the system works to manage rising costs, operators must track how shifting Medicaid and federal subsidies impact health sector stability.

Ascension recorded a $371 million reduction in operating losses year-over-year while generating $109 million in core operating income. The health system, which completed its $3.9 billion Amsurg acquisition in June 2026, expects its cash-to-adjusted debt ratio to remain between 150% and 160%.

The players

Ascension

A major nonprofit health system operating 91 hospitals and 312 surgery centers across 36 states.

Moody's Ratings

A global credit agency that evaluates the financial health and risk profiles of institutional borrowers.

Amsurg

A provider of ambulatory surgery center services recently acquired by Ascension to expand non-acute care.

The details

Ascension is leveraging its extensive national footprint to drive organizational efficiencies and scale its non-acute service capacity. By acquiring Amsurg, the system aims to accelerate growth in specialized surgical care outside of traditional hospital settings. However, the system faces projected operational pressures linked to the expiration of enhanced ACA subsidies and a future reliance on Medicaid supplemental funding.

End of 2025: Expiration of enhanced ACA subsidies.
June 2026: Completion of Amsurg acquisition.
June 30, 2026: End of fiscal year 2026.
October 1, 2026: Moody's released ratings report.
2028: Additional operational pressure begins.

Market Landscape

The rating affirmation follows a broader industry pattern where health systems are consolidating non-acute assets to diversify revenue. The report specifically ties future operational pressure to the expiration of ACA subsidies and the variability of Medicaid supplemental funding.

Operators should monitor how the expiration of ACA subsidies affects patient payer mix and regional reimbursement rates. Reviewing exposure to Medicaid-reliant revenue streams is advised, as health systems face tightening margins entering 2028.

The takeaway

Large-scale acquisitions remain a primary tool for health systems attempting to stabilize operations through non-acute service growth. Keep a close watch on federal subsidy policies, as any contraction will likely force mid-market operators to re-evaluate their reliance on government programs.